Oedema detection

Information

  • Patent Grant
  • 8615292
  • Patent Number
    8,615,292
  • Date Filed
    Friday, June 17, 2005
    19 years ago
  • Date Issued
    Tuesday, December 24, 2013
    10 years ago
  • US Classifications
    Field of Search
    • US
    • 600 547000
    • 600 300000
    • 600 306000
    • 600 546000
    • 600 587000
    • 607 001-003
    • 607 005000
    • 607 006000
    • 607 059000
    • 128 920000
    • 128 923000
    • 702 127000
    • 702 189000
  • International Classifications
    • A61B5/00
    • Term Extension
      1416
Abstract
A method of detecting tissue oedema in a subject. The method includes determining a measured impedance for first and second body segments. An index indicative of a ratio of the extra-cellular to intra-cellular fluid is then calculated for each body segment, with these being used to determine an index ratio based on the index for the first and second body segments. The index ratio can in turn be used to determine the presence, absence or degree of tissue oedema, for example by comparing the index ratio to a reference or previously determined index ratios.
Description
RELATED APPLICATIONS

This application is a U.S. National Phase under 35 USC §371 of the International Application No.: PCT/AU2005/000876, filed on Jun. 17, 2005, designating the U.S. and published in English on Dec. 15, 2005 as WO/2005/122888, which claims the benefit of priority of Australian Application No. 2004903314, filed on Jun. 18, 2004, each of which is incorporated by reference.


BACKGROUND OF THE INVENTION

The present invention relates to a method and apparatus for detecting tissue oedema, and in particular, to a method and apparatus for detecting tissue oedema using impedance measurements.


DESCRIPTION OF THE PRIOR ART

The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that the prior art forms part of the common general knowledge.


Lymphoedema is a condition characterised by excess protein and oedema in the tissues as a result of reduced lymphatic transport capacity and/or reduced tissue proteolytic capacity in the presence of a normal lymphatic load. Acquired, or secondary lymphoedema, is caused by damaged or blocked lymphatic vessels. “The commonest inciting events are surgery and/or radiotherapy. However, onset of lymphoedema is unpredictable and may develop within days of its cause or at any time during a period of many years after that cause.


WO00/79255 describes a method of detection of oedema by measuring bioelectrical impedance at two different anatomical regions in the same subject at a single low frequency alternating current. The two measurements are analysed to obtain an indication of the presence of tissue oedema by comparing with data obtained from a normal population.


Other known methods of analysis of bioelectrical impedance measurements involve determining a phase and amplitude value for the measured signals. The measurement of amplitude is straightforward but the measurement of phase is more complicated and therefore the required equipment is costly.


SUMMARY OF THE PRESENT INVENTION

In a first broad form the present invention provides a method of detecting tissue oedema in a subject, the method including, in a processing system:

    • a) determining a measured impedance for first and second body segments;
    • b) for each body segment, and using the measured impedance, determining an index indicative of a ratio of the extra-cellular to intra-cellular fluid;
    • c) determining an index ratio based on the index for the first and second body segments;
    • d) determining the presence, absence or degree of tissue oedema based on the index ratio.


Typically the method includes, in the processing system:

    • a) comparing the index ratio to at least one reference; and,
    • b) determining the presence, absence or degree of tissue oedema based on the results of the comparison.


Typically the reference includes at least one of:

    • a) a predetermined threshold;
    • b) a tolerance determined from a normal population; and,
    • c) a predetermined range.


Typically the reference includes an index ratio previously determined for the subject.


Typically the previously determined index ratio is determined prior to the subject undergoing at least one of:

    • a) surgery; and,
    • b) treatment.


Typically the first and second body segments are different types of body segment.


Typically the first and second body segments are limbs.


Typically the first body segment is a leg and the second body segment is an arm.


Typically the method includes, in the processing system:

    • a) determining a plurality of measured impedances for each body segment, each measured impedance being measured at a corresponding measurement frequency; and,
    • b) determining the index ratio based on the plurality of measured impedances.


Typically the method includes, in the processing system:

    • a) determining values for parameters R0 and R from the measured impedance values; and,
    • b) calculating the index (I) using the equation:






I
=


R




R
0

-

R












      • where:
        • R0 is the resistance at zero frequency; and,
        • R is the resistance at infinite frequency.







Typically the method includes, in the processing system, determining the parameter values using the equation:






Z
=


R


+



R
0

-

R




1
+


(

j





ω





τ

)


(

1
-
α

)











    • where:
      • Z is the measured impedance at angular frequency ω,
      • τ is a time constant, and
      • α has a value between 0 and 1; and





Typically the method includes, in the processing system:

    • a) determining the impedance of each body segment at four discrete frequencies; and,
    • b) determining values for the parameters by solving the equation using four simultaneous equations.


Typically the method includes, in the processing system, determining the parameter values by:

    • a) determining an impedance locus using the measured impedance values; and,
    • b) using the impedance locus to determine the parameter values.


Typically the method includes, in the computer system, displaying an indication of at least one of:

    • a) the parameter values;
    • b) the ratio of extra-cellular to intra-cellular fluid; and,
    • c) an indication of the at least one of the presence, absence or degree of tissue oedema in the subject.


In a second broad form the present invention provides apparatus for detecting tissue oedema in a subject, the apparatus including a processing system for:

    • a) determining a measured impedance for first and second body segments;
    • b) for each body segment, and using the measured impedance, determining an index indicative of a ratio of the extra-cellular to intra-cellular fluid;
    • c) determining an index ratio based on the index for the first and second body segments;
    • d) determining the presence, absence or degree of tissue oedema based on the index ratio.


Typically the apparatus includes:

    • a) a current supply for generating an alternating current at each of a plurality of frequencies;
    • b) at least two supply electrodes for applying the generated alternating current to a subject;
    • c) at least two measurement electrodes for detecting a voltage across the subject; and,
    • d) a sensor coupled to the measurement electrodes for determining the voltage, the sensor being coupled to the processing system to thereby allow the processing system to determine the measured impedances.


Typically the apparatus is adapted to perform the method of the first broad form of the invention.


In a third broad form the present invention provides a method of diagnosing tissue oedema in a body region, the method including:

    • a) applying an alternating current signal at four or more discrete frequencies;
    • b) measuring an impedance at each frequency;
    • c) solving the equation:






Z
=


R


+



R
0

-

R




1
+


(

j





ω





τ

)


(

1
-
α

)










to obtain parameters R0, R, τ and α,

    • where:
      • Z is the measured impedance at angular frequency ω,
      • R0 is the resistance at zero frequency,
      • R is the resistance at infinite frequency,
      • τ is a time constant, and
      • α has a value between 0 and 1; and
    • d) using one or more of the parameters R0, R, α and α to diagnose tissue oedema in the body region.


Typically the method includes diagnosing tissue oedema by determining the presence, absence or degree of tissue oedema.


Typically the method includes:

    • a) determining the impedance at four discrete frequencies; and,
    • b) determining values for the parameters by solving the equation using four simultaneous equations.


Typically the method includes:

    • a) determining values of one or more of the parameters R0, R, τ and α for first and second body regions;
    • b) comparing the results from the first body region with the results from the second body region to obtain an indication of the presence of tissue oedema.


Typically the method includes:

    • a) comparing the parameters Ro and R for each body region; and,
    • b) indicating tissue oedema if the difference is outside a tolerance determined from a normal population.


Typically the method includes:

    • a) calculating an index Ri/Re as indicative of the ratio of extracellular fluid to intracellular fluid;
      • where
        • Re is the resistance of extracellular fluid determined from Re=R0; and,
        • Ri is the resistance of intracellular fluid determined from








R
i

=



R




R
e




R
e

-

R





;
and






    • b) diagnosing tissue oedema in accordance with the determined index.





Typically the method includes indicating tissue oedema by displaying the indication as a position on a scale.


Typically the method is a method according to the first broad form of the invention.


In a fourth broad form the present invention provides apparatus for detecting tissue oedema, the apparatus including:

    • a) a current supply for applying an alternating current to an anatomical region at four or more discrete frequencies across a frequency range;
    • b) a monitor for monitoring the bioelectrical impedance of said region; and
    • c) a processing system for:
      • i) analysing the bioelectrical impedance by solving:






Z
=


R


+



R
0

-

R




1
+


(

j





ω





τ

)


(

1
-
α

)










to obtain parameters R0, R, τ and α,

    • where:
      • Z is the measured impedance at angular frequency ω,
      • R0 is the resistance at zero frequency,
      • R is the resistance at infinite frequency,
      • τ is a time constant, and
      • α has a value between 0 and 1; and
      • ii) using one or more of the parameters R0, R, τ and α to provide an indication of tissue oedema.


Typically the current supply includes a proximal electrode and distal electrode in electrical correction with a power source.


Typically the monitor includes a first connection and second connection for location on or near the anatomical region.


Typically the monitor includes display means to display the signals indicative of bioimpedance.


Typically the processing system is suitably programmed to perform analysis of data to provide an indication of the presence of tissue oedema.


Typically the apparatus is adapted to perform the method of the third broad form of the invention.


In a fifth broad form the present invention provides a method of diagnosing tissue oedema in a body region, the method including:

    • a) calculating an index Ri/Re as indicative of the ratio of extracellular fluid to intracellular fluid;
      • where:
        • Re is the resistance of extracellular fluid determined from Re=R0; and,
        • Ri is the resistance of intracellular fluid determined from








R
i

=



R




R
e




R
e

-

R





;
and






    • b) indicating the presence of tissue oedema if there is a change in the index Ri/Re over time.





Typically the method includes:

    • a) measuring of Ri/Re is made prior to an event likely to cause oedema; and,
    • b) comparing to a measurement of Ri/Re made after the event.


Typically the method is a method according to the first or third broad forms of the invention.


In a sixth broad form the present invention provides apparatus for diagnosing tissue oedema in a body region, the apparatus including a processing system for:

    • a) calculating an index Ri/Re as indicative of the ratio of extracellular fluid to intracellular fluid;
      • where:
        • Re is the resistance of extracellular fluid determined from Re=R0; and,
        • Ri is the resistance of intracellular fluid determined from








R
i

=



R




R
e




R
e

-

R





;
and






    • b) indicating the presence of tissue oedema if there is a change in the index Ri/Re over time.





Typically the apparatus is adapted to perform the method of the fifth broad form of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

An example of the present invention will now be described with reference to the accompanying drawings, in which: —



FIG. 1 is a schematic of an example of a theoretical equivalent circuit for biological tissue;



FIG. 2 is an example of a locus of impedance known as a Cole-Cole plot;



FIG. 3 is a schematic of an example of a single channel bioimpedance apparatus;



FIG. 4 is a schematic of an example of a dual channel bioimpedance apparatus; and,



FIG. 5 is a flow chart of an example of a process for evaluating tissue oedema.





DETAILED DESCRIPTION OF THE DRAWINGS


FIG. 1 is an example of an equivalent circuit that effectively models the electrical behaviour of biological tissue. The equivalent circuit has two branches that represent current flow through extracellular fluid and intracellular fluid. The extracellular component of biological impedance is represented by Re and the intracellular component is represented by Ri. Capacitance of the cell membrane in the intracellular path is represented by C.


The relative magnitudes of the extracellular and intracellular components of impedance of an alternating current (AC) are frequency dependent. At zero frequency the capacitor acts as a perfect insulator and all current flows through the extracellular fluid, hence the resistance at zero frequency, R0, equals Re. At infinite frequency the capacitor acts as a perfect conductor and the current passes through the parallel resistive combination. The resistance at infinite frequency is given by R=RiRe/(Ri+Re). The measured values of R0 and R would therefore directly provide the values of Re and Ri. required for estimation of extracellular water (ECW) and intracellular water (ICW), which lead to identification of oedema by comparison between affected and unaffected body regions. However, as is well known, the practical constraints of skin-electrode impedance do not permit application of DC or very high frequency AC currents, hence the values of the frequencies commonly used can only approximate the ideal measurement frequencies.


The impedance of the equivalent circuit of FIG. 1 at an angular frequency ω, where ω=2π*frequency, is given by:









Z
=


R


+



R
0

-

R




1
+

(

j





ω





τ

)








(
1
)








where:

    • R=RiRe/(Ri+Re),
    • R0=Re and,
    • τ is the time constant of the capacitive circuit.


These values can be estimated by extrapolating what is known as a Cole-Cole plot, which is a plot of the vector sum of the resistance R and reactance X that sum to impedance Z. A Cole-Cole plot of reactance against resistance is shown in FIG. 2 with an impedance vector Z at a given frequency.


It is also known that biological specimens deviate from the equivalent circuit because the cell membrane is an imperfect capacitor and there is a large variation between cell types in the current path. This results in a Cole-Cole plot of a biological specimen having a depressed centre compared to the equivalent circuit plot shown in FIG. 2. A more accurate expression for impedance in a biological sample is therefore given by:









Z
=


R


+



R
0

-

R




1
+


(

j





ω





τ

)


(

1
-
α

)









(
2
)








where α has a value between 0 and 1 and can be thought of as an indicator of the deviation of a real system from the ideal model.


Another important value is the impedance Zc at the peak of the locus in FIG. 2. This peak occurs when ω=1/τ which is referred to as the characteristic angular frequency, ωc which equals 2πfc.


As explained above, the prior art approach to determining the desired values of R0 and R has been to make impedance measurements at multiple frequencies and to construct a section of a Cole-Cole plot. The plot can be extrapolated to determine R0, R and Zc. This procedure takes a significant amount of processing time and therefore makes real time monitoring of bioimpedance problematic. Furthermore, the measurements require determination of both phase and amplitude values which require relatively sophisticated, and therefore expensive, equipment.


Equation (2) has four, unknowns, R0, R and α. The values of these unknowns can be determined by taking measurements at four discrete frequencies, and solving four simultaneous equations. Any of the established methods such as matrix inversion or numerical iteration can be used to solve the equations for the unknown values.


The values determined by this process compare favourably with the values obtained by the conventional curve fitting technique, in which measured impedances are used to plot a locus similar to that shown in FIG. 2, thereby allowing values of R0 and R to be obtained.


Greater, accuracy can be achieved by taking measurements at a larger number of frequencies, albeit at a cost in processing overhead. Furthermore, accurate results can usefully be derived by selecting discrete frequencies that span the range of frequencies normally used in multiple frequency bioelectrical impedance analysis (51 KHz to 1000 KHz).


Once the values of R0, R and Zc are determined they can be used in various ways to detect and quantify oedema in a body region. One approach to this quantification is to compare measurements taken at a first body region against measurements taken at a second body region.


The second measurements may be taken in a paired unaffected body region. For example, a first measurement may be made at a location on the left leg and a second measurement made at the same location on the right leg of the same patient where the right leg is unaffected by tissue oedema. It is clear to a skilled addressee that other paired anatomical regions may be similarly used when performing the above described methodology. For example, paired areas of the thorax may be assessed.


It is, however, possible to take the second measurement at a dissimilar body region. For example, the first reading may be taken on a leg, and a second reading may be taken on an arm. The analysis of these readings will necessarily involve some different considerations. Again, it is clear to a skilled addressee that a wide range of dissimilar anatomical structures may be used for these measurements, such as a leg and the chest wall. This form of the method is of particular use where two paired anatomical sites are both affected by tissue oedema. The comparison of readings taken in two such affected sites will be distorted and will not produce a reliable indicator of tissue oedema.


As a further alternative, the method may be applied to two or more measurements on the same anatomical region of a subject where those readings are separated in time. For example, a series of readings may be taken on a single limb prior to and subsequent to surgery with a known risk of lymphoedema as a side effect. Analysis of any two or more readings may indicate the early stage of developing lymphoedema and thereby provide a distinct advantage in that the prognosis may be greatly improved by early and aggressive therapeutic intervention. This technique may also be used to monitor the progress of oedema with comparison made between measurements of an affected site.


In the case of comparison of any two dissimilar regions it is known that a correcting factor may be required. A correcting factor may be established by surveying a population of clinically unaffected subjects:


Another approach is a modification of the technique described in a publication, (Cornish, B. H.; Thomas B. J.; Ward L. C.; Angiology Vol 53, No 1, pp 41-47 2002). In this approach the measured parameters are used to calculate an index Ri/Re. as indicative of the ratio of extracellular fluid to intracellular fluid. The extracellular fluid resistance Re is determined from

Re=R0

and intracellular fluid resistance Ri is determined from







R
i

=




R




R
e




R
e

-

R




.





Thus, the index I, which is indicative of the ratio of extra- to intra-cellular fluid is given by the equation:









I
=



R
i


R
e


=


R




R
0

-

R









(
3
)







This approach has particular application to monitoring oedema overtime as a plot of the index against time can disclose the onset and rate of advance of oedema.


Referring to FIG. 3, there is shown a schematic of an apparatus for measuring impedance, including an oscillator 20, divider 21 and filter 22 connected in series to produce alternating current at a number of discrete frequencies when connected to a power, source (not shown). The alternating current passes through cable 23 to electrode 24 through intervening tissue (not shown) to electrode 25, which is connected to a reference 26 via cable 27.


Monitoring electrodes 28, 29 are in connection with bioimpedance measuring meter 30 via cables 31, 32. Signals from bioimpedance measuring meter 30 are passed to analogue/digital converter 33, which is in signal connection with data storing unit 34, which retains the digitised reading of bioimpedance.


The applied signal is suitably derived from a constant current source to ensure that the generated current does not exceed the Australian Standard of a maximum of 32V and a maximum current of 100 μA at 10 kHz. The current limit increases to an upper threshold of 1 mA at 1000 kHz. The applied signal could be derived from a constant voltage source rather than a constant current source providing a mechanism is provided to maintain the safety standard.


A first reading of bioelectrical impedance is taken from a first anatomical region of a subject and stored in data storing unit 34.


The processor 35 calculates the values R0, R, τ and α by solving the equation (2) and transfers the result to second data storing unit 36. The values may also be presented on display 37.


The processor may also calculate an indicator of oedema, such as the Ri/Re index, and display this on a scale with a movable indicator. There may also be a simple series of lights which, when illuminated, indicate any one of “unaffected”, “possibly affected” or “affected”. The display may be any other suitable form of indicator.


It is more convenient for many of the techniques for assessing oedema to use a two-channel bioimpedance meter as shown in FIG. 4. In this case, current is passed between the electrodes 24, 25 on, for example, one arm 47 and between the electrodes 24A, 25A on the opposite arm 48. This can be achieved either sequentially, for example through the use of multiplexing, or simultaneously. Monitoring electrodes 28, 29 on the first arm 47 measure bioelectrical impedance while monitoring electrodes 28A, 29A measure bioelectrical impedance on the opposite arm 48. A measuring meter 30 has two channels for simultaneously monitoring signals provided from the monitoring electrodes 28, 29; 28A; 29A. The signals are passed through an analogue/digital converter 33 and then analysed by processor 35. The results are stored in memory 36 and shown on display 37.


Accordingly the processor 35 operates to analyse the impedance signals and use this to provide an evaluation of the presence, absence or degree of tissue oedema. This is typically performed in accordance with applications software provided in the memory. It will be appreciated from this that the processor 35, the memory 36 and the display 37 may typically be formed from a processing system, such as a computer system, computer server, desktop computer, lap-top, specialised hardware, or the like.


An example of the process for monitoring the impedance signals and evaluating tissue oedema will now be described with reference to the flowchart shown in FIG. 5.


In particular, at step 600, the impedance at first and second body segments are measured using the apparatus shown in FIG. 4. In this example, the body segments are different body segments and may include for example an arm and a leg.


At step 610 the processor 35 determines values of R0 and R for each body segment. This can be achieved using a number of mechanisms. For example, given that there are four unknown parameters R0, R, τ, α, the equation (2) can be used to determine four simultaneous equations, which can then be solved using appropriate mathematical techniques. Alternatively, the measured impedance values can be plotted to derive an arc similar to that shown in FIG. 2, which then further allows the values of R0 and R to be determined. Alternative techniques may also be used.


At step 620 the values of R0 and R are used to determine an index I for each body segment. The index is based on the ratio of the extracellular to intracellular fluid and is therefore calculated using equation (3).


At step 630 an index ratio IR based on a ratio of the first body segment index I1 to second body segment index I2 is calculated, with this being used in evaluating the presence, absence or degree of oedema.


This is possible, as, for a healthy subject, there is generally a degree of similarity of intra- and extra-cellular fluid levels, even between different body segments. Thus, for example, if the subject is suffering from a condition other than oedema, which causes a general change in the ratio of extra- to intra-cellular fluid, then this should affect all body segments roughly equally. As a result, assuming that neither body segment has tissue oedema, then the index ratio IR should remain relatively constant for a given individual.


It will be appreciated that in the event that the properties of each body segment are equal, then the index ratio should have a value in the region of 1. Typically however, minor variations in tissue will occur between different body segments, and this can be accounted for in one of two ways.


Firstly, as shown at step 640, the index ratio IR can be compared to a predetermined range. In this case, the range is used to account for variations between body segments that are not attributable to tissue oedema. It will therefore be appreciated that the range is therefore typically set to take into account the difference in index ratio IR between different body portions in a number of different subjects. This range can therefore be set based on data collected from a number of healthy subjects.


In any event, if the index ratio IR falls outside the predetermined range, then this is used by the processor 35 to determine that tissue oedema is present in one of the body segments at step 650.


Furthermore, an assessment of the value of the index ratio IR can be used in assessing the degree of tissue oedema. Thus, for example, a number of value ranges can be defined, with each range corresponding to a different degree of oedema. In this instance, the processor 35 determines within which range the index ratio IR falls, and uses this to generate an indication of the likely degree of tissue oedema.


The value of the index ratio IR will also depend on the body segments that have been selected and accordingly, in general a different range will be selected for the comparison depending on the body segments under consideration.


It will also be appreciated that the index ratio IR can be used to indicate in which body segment the oedema is present, and this can be based on whether the index ratio IR is greater than or less than 1.


The index ratio IR may also depend on a number of factors, such as the subject's age, weight, sex and height, and again a respective range can be selected based on these factors. However, to avoid the need for an assessment of such factors, an alternative process of longitudinal analysis can be performed.


In this case, at step 660 the processor 35 can compare the index ratio IR to previously determined index ratios IRprev measured for the same subject, on the same body segments. In this situation, the previously determined index ratios IRprev are preferably determined prior to the onset of oedema but this is not essential.


In any event, previous measurements of the same body segments on the same subject will automatically account for inherent variations in tissue properties, which in turn cause different values for the ratio of extra- to intra-cellular fluid even if tissue oedema is not present.


In this case, the processor 35 assesses whether the current index ratio IR value is different to the previous index ratio IRprev. If there is change in the value, then the direction in change in value can indicate either increasing or decreasing levels of tissue oedema, with the magnitude of the change being used to indicate a degree of change at step 650.


In general, at step 650, the display 37 is used to display an indication of one or more of:

    • one or more index ratios
    • one or more indexes; and,
    • the presence, absence or degree of tissue oedema.


It will therefore be appreciated from this that the above-described methodology provides two different methods of determining the onset for oedema. This can be achieved either by performing a longitudinal analysis in which the index ratio IR is compared to previously determined index ratios IRprev. Alternatively the index ratio IR can be compared to one or more absolute index ratio ranges.


In practice, a combination for the two approaches will generally be used. Thus, for example, when a patient is first admitted for a procedure to be performed, a comparison to absolute index ratio ranges may be used to confirm that it is unlikely that the patient has oedema.


The measured index ratio IR can then be used to form the reference value of the index ratio IRprev, allowing subsequent measurements to be compared thereto.


By using the index ratio IR described above, this allows variation in tissue properties between different body portions to be taken into account when assessing the presence, absence or degree of tissue oedema, and accordingly, this allows the onset of bilateral oedema to be detected. This is in contrast to previous techniques, in which like body segments are compared. In this case, if impedance measurements of a limb, such as a leg, are compared to measurements from the other corresponding limb, then in the event that oedema is present in both limbs, the impedance measurements will be similar, and will not therefore indicate that oedema is present.


As mentioned above, the values of R0 and R can be determined in any one of a number of ways. However, in general it is preferred to be able to determine the values in real-time to thereby vastly enhance the oedema assessment process. In particular, this allows measurements to be made of the patient, with the processor 35 generating an indication of the degree of tissue oedema in real-time.


The discussion has referred to both oedema and lymphoedema, as it is clear to a skilled addressee that the above method and apparatus may be utilised on any form of tissue oedema. However, it is also likely that the predominant use of the method, and apparatus will be directed mainly to lymphoedema due to its clinical relevance. However, this may change in a specific situation or with time. The method may also be used in comparing a reading from one anatomical region with a separate unpaired region. For example, a reading taken on central localised oedema (eg: ascites) may be referenced against a nonoedematous structure such as a limb.


Throughout the specification, the aim has been to describe the preferred embodiments of the invention without limiting the invention to any one embodiment or specific collection of features. Various changes and modifications may be made to the embodiments described and illustrated without departing from the present invention.

Claims
  • 1. A method of detecting tissue oedema in a subject, the method comprising: a) determining a measured impedance for a first body segment;b) determining a measured impedance for a second body segment, the second body segment being different from the first body segment;c) for each body segment, and using the respective measured impedance, determining, using a processor of a processing system, an index indicative of a ratio of the extra-cellular to intra-cellular fluid;d) determining, using the processor of the processing system, an index ratio based on the index for the first and second body segments; ande) determining the presence, absence or degree of tissue oedema based on the index ratio.
  • 2. A method according to claim 1, wherein the method includes, in the processing system: a) comparing the index ratio to at least one reference; andb) determining the presence, absence or degree of tissue oedema based on the results of the comparison.
  • 3. A method according to claim 2, wherein the reference includes at least one of: a) a predetermined threshold;b) a tolerance determined from a normal population; andc) a predetermined range.
  • 4. A method according to claim 2, wherein the reference includes an index ratio previously determined for the subject.
  • 5. A method according to claim 4, wherein the previously determined index ratio is determined prior to the subject undergoing at least one of: a) surgery; andb) treatment.
  • 6. A method according to claim 1, wherein the first and second body segments are different types of body segments.
  • 7. A method according to claim 1, wherein the first and second body segments are limbs.
  • 8. A method according to claim 1, wherein the first body segment is a leg and the second body segment is an arm.
  • 9. A method according to claim 1, wherein the method includes, in the processing system: a) determining a plurality of measured impedances for each body segment, each measured impedance being measured at a corresponding measurement frequency; and,b) determining the index ratio based on the plurality of measured impedances.
  • 10. A method according to claim 9, wherein the method includes, in the processing system: a) determining values for parameters R0 and R∞ from the measured impedance values; and,b) calculating the index (I) using the equation:
  • 11. A method according to claim 10, wherein the method includes, in the processing system, determining the parameter values using the equation:
  • 12. A method according to claim 11, wherein the method includes, in the processing system: a) determining the impedance of each body segment at four discrete frequencies; and,b) determining values for the parameters by solving the equation using four simultaneous equations.
  • 13. A method according to claim 10, wherein the method includes, in the processing system, determining the parameter values by: a) determining an impedance locus using the measured impedance values; andb) using the impedance locus to determine the parameter values.
  • 14. A method according to claim 1, wherein the method includes, in the processing system, displaying an indication of at least one of: a) the parameter values;b) the ratio of extra-cellular to intra-cellular fluid; and,c) an indication of the at least one of the presence, absence or degree of tissue oedema in the subject.
  • 15. A method according to claim 1, wherein the processing system is coupled to an apparatus comprising: a) a current supply for generating an alternating current at each of a plurality of frequencies;b) at least two supply electrodes for applying the generated alternating current to a subject;c) at least two measurement electrodes for detecting a voltage across the subject; and,d) a sensor coupled to the measurement electrodes for determining the voltage, the sensor being coupled to the processing system to thereby allow the processing system to determine the measured impedances.
Priority Claims (1)
Number Date Country Kind
2004903314 Jun 2004 AU national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/AU2005/000876 6/17/2005 WO 00 3/25/2008
Publishing Document Publishing Date Country Kind
WO2005/122888 12/29/2005 WO A
US Referenced Citations (150)
Number Name Date Kind
3316896 Thomasset May 1967 A
3851641 Toole et al. Dec 1974 A
3871359 Pacela Mar 1975 A
4008712 Nyboer Feb 1977 A
4034854 Bevilacqua Jul 1977 A
4144878 Wheeler Mar 1979 A
4184486 Papa Jan 1980 A
4291708 Frei et al. Sep 1981 A
4314563 Wheeler Feb 1982 A
4365634 Bare et al. Dec 1982 A
4407288 Langer et al. Oct 1983 A
4407300 Davis Oct 1983 A
4450527 Sramek May 1984 A
4458694 Sollish et al. Jul 1984 A
4468832 Batchelor Sep 1984 A
4486835 Bai et al. Dec 1984 A
4537203 Machida Aug 1985 A
4539640 Fry et al. Sep 1985 A
4557271 Stoller et al. Dec 1985 A
4583549 Manoli Apr 1986 A
4602338 Cook Jul 1986 A
4617939 Brown et al. Oct 1986 A
4646754 Seale Mar 1987 A
4686477 Givens et al. Aug 1987 A
4688580 Ko et al. Aug 1987 A
4763660 Kroll et al. Aug 1988 A
4793362 Tedner Dec 1988 A
4895163 Libke et al. Jan 1990 A
4911175 Shizgal Mar 1990 A
4942880 Sloväk Jul 1990 A
4951682 Petre Aug 1990 A
5025784 Shao et al. Jun 1991 A
5063937 Ezenwa et al. Nov 1991 A
5143079 Frei et al. Sep 1992 A
5197479 Hubelbank et al. Mar 1993 A
5246008 Meuller Sep 1993 A
5280429 Withers Jan 1994 A
5311878 Brown et al. May 1994 A
5372141 Gallup et al. Dec 1994 A
5415164 Faupel May 1995 A
5449000 Libke et al. Sep 1995 A
5465730 Zadehkoochak et al. Nov 1995 A
5469859 Tsoglin et al. Nov 1995 A
5503157 Sramek Apr 1996 A
5505209 Reining Apr 1996 A
5529072 Sramek Jun 1996 A
5544662 Saulnier et al. Aug 1996 A
5588429 Isaacson et al. Dec 1996 A
5704355 Bridges Jan 1998 A
5732710 Rabinovich et al. Mar 1998 A
5746214 Brown et al. May 1998 A
5759159 Masreliez Jun 1998 A
5788643 Feldman Aug 1998 A
5800350 Coppleson et al. Sep 1998 A
5807251 Wang et al. Sep 1998 A
5807270 Williams Sep 1998 A
5807272 Kun et al. Sep 1998 A
5810742 Pearlman Sep 1998 A
5919142 Boone et al. Jul 1999 A
6011992 Hubbard et al. Jan 2000 A
6015389 Brown Jan 2000 A
6018677 Vidrine et al. Jan 2000 A
6122544 Organ Sep 2000 A
6125297 Siconolfi Sep 2000 A
6142949 Ubby Nov 2000 A
6151523 Rosell Ferrer et al. Nov 2000 A
6173003 Whikehart et al. Jan 2001 B1
6228022 Friesem et al. May 2001 B1
6233473 Shepherd et al. May 2001 B1
6236886 Cherepenin et al. May 2001 B1
6256532 Cha Jul 2001 B1
6292690 Petrucelli et al. Sep 2001 B1
6339722 Heethaar et al. Jan 2002 B1
6354996 Drinan et al. Mar 2002 B1
6496725 Kamada et al. Dec 2002 B2
6532384 Fukuda Mar 2003 B1
6569160 Goldin et al. May 2003 B1
6584348 Glukhovsky Jun 2003 B2
6618616 Iijima et al. Sep 2003 B2
6625487 Herleikson Sep 2003 B2
6631292 Liedtk Oct 2003 B1
6633777 Szopinski Oct 2003 B2
6643543 Takehara et al. Nov 2003 B2
6714813 Ishigooka et al. Mar 2004 B2
6714814 Yamada et al. Mar 2004 B2
6723049 Skladnev et al. Apr 2004 B2
6724200 Fukuda Apr 2004 B2
6760617 Ward et al. Jul 2004 B2
6768921 Organ et al. Jul 2004 B2
6845264 Skladnev et al. Jan 2005 B1
6870109 Villarreal Mar 2005 B1
6906533 Yoshida Jun 2005 B1
6922586 Davies Jul 2005 B2
7130680 Kodama et al. Oct 2006 B2
7148701 Park et al. Dec 2006 B2
7212852 Smith et al. May 2007 B2
7457660 Smith et al. Nov 2008 B2
7477937 Iijima et al. Jan 2009 B2
7706872 Min et al. Apr 2010 B2
20010007056 Linder et al. Jul 2001 A1
20010020138 Ishigooka et al. Sep 2001 A1
20010025139 Pearlman Sep 2001 A1
20020020138 Walker et al. Feb 2002 A1
20020072686 Hoey et al. Jun 2002 A1
20020079910 Fukuda Jun 2002 A1
20020093992 Plangger Jul 2002 A1
20020123694 Organ et al. Sep 2002 A1
20020161311 Ward et al. Oct 2002 A1
20020194419 Rajput et al. Dec 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030050570 Kodama et al. Mar 2003 A1
20030073916 Yonce Apr 2003 A1
20030105411 Smallwood et al. Jun 2003 A1
20030120170 Zhu et al. Jun 2003 A1
20040015095 Li et al. Jan 2004 A1
20040019292 Drinan et al. Jan 2004 A1
20040077944 Steinberg et al. Apr 2004 A1
20040158167 Smith et al. Aug 2004 A1
20040167423 Pillon et al. Aug 2004 A1
20040181164 Smith et al. Sep 2004 A1
20040186392 Ward et al. Sep 2004 A1
20040210150 Virtanen Oct 2004 A1
20040210158 Organ et al. Oct 2004 A1
20040252870 Reeves et al. Dec 2004 A1
20050033281 Bowman et al. Feb 2005 A1
20050039763 Kraemer et al. Feb 2005 A1
20050098343 Fukuda May 2005 A1
20050101875 Semler et al. May 2005 A1
20050137480 Alt et al. Jun 2005 A1
20050151545 Park et al. Jul 2005 A1
20050177062 Skrabal et al. Aug 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050203435 Nakada Sep 2005 A1
20050261743 Kroll Nov 2005 A1
20060004300 Kennedy Jan 2006 A1
20060085048 Cory et al. Apr 2006 A1
20060085049 Cory et al. Apr 2006 A1
20060116599 Davis Jun 2006 A1
20060122523 Bonmassar et al. Jun 2006 A1
20060122540 Zhu et al. Jun 2006 A1
20060224079 Washchuk Oct 2006 A1
20060264775 Mills et al. Nov 2006 A1
20060270942 McAdams Nov 2006 A1
20070027402 Levin et al. Feb 2007 A1
20080002873 Reeves et al. Jan 2008 A1
20080009757 Tsoglin et al. Jan 2008 A1
20080039700 Drinan et al. Feb 2008 A1
20080205717 Reeves et al. Aug 2008 A1
20090043222 Chetham Feb 2009 A1
20090177099 Smith et al. Jul 2009 A1
Foreign Referenced Citations (48)
Number Date Country
2231038 Nov 1999 CA
2912349 Oct 1980 DE
0249823 Dec 1987 EP
349043 Mar 1990 EP
0357309 Mar 1990 EP
377887 Jul 1990 EP
865763 Sep 1998 EP
0869360 Oct 1998 EP
1146344 Oct 2001 EP
1114610 Nov 2001 EP
1177760 Feb 2002 EP
1219937 Jul 2002 EP
1338246 Aug 2003 EP
1452131 Sep 2004 EP
2486386 Jan 1982 FR
2131558 Jun 1984 GB
2260416 Apr 1993 GB
09051884 Feb 1997 JP
9220209 Aug 1997 JP
10000185 Jan 1998 JP
10014898 Jan 1998 JP
10014899 Feb 1998 JP
10-225521 Aug 1998 JP
11070090 Mar 1999 JP
2000139867 May 2000 JP
2001321352 Nov 2001 JP
2002330938 Nov 2002 JP
WO 8807392 Oct 1988 WO
WO 9612439 May 1996 WO
WO 9632652 Oct 1996 WO
WO 9711638 Apr 1997 WO
WO 9823204 Jun 1998 WO
WO 9833553 Aug 1998 WO
WO 0040955 Jul 2000 WO
WO 0079255 Dec 2000 WO
WO 0150954 Jul 2001 WO
WO 0167098 Sep 2001 WO
WO 02062214 Aug 2002 WO
WO 02094096 Nov 2002 WO
WO 04000115 Dec 2003 WO
WO 2004026136 Apr 2004 WO
WO 2004047635 Jun 2004 WO
WO 2004049936 Jun 2004 WO
WO 2004083804 Sep 2004 WO
WO 2005010640 Feb 2005 WO
WO 2005027717 Mar 2005 WO
WO 2005018432 Mar 2005 WO
WO 2005051194 Jun 2005 WO
Non-Patent Literature Citations (51)
Entry
European Search Report dated Jun. 27, 2005 and Written Opinion dated Jul. 6, 2005 for PCT/AU2005/000876 filed Jun. 17, 2005.
Abdullah M. Z.; Simulation of an inverse problem in electrical impedance tomography using resistance electrical network analogues; International Journal of Electrical Engineering Education; vol. 36, No. 4, pp. 311-324; Oct. 1999.
Al-Hatib, F.; Patient Instrument connection errors in bioelectrical impedance measurement; Physiological Measurement; vol. 19, No. 2, pp. 285-296; May 2, 1998.
Boulier, A. et al.; Fat-Free Mass Estimation by Two Electrode Impedance Method; American Journal of Clinical Nutrition; vol. 52, pp. 581-585; 1990.
Chaudary, S.S. et al.; Dielectric Properties of Normal & Malignant Human Breast Tissues at Radiowave and Microwave Frequencies; Indian Journal of Biochemistry & Biophysics; vol. 21, No. 1, pp. 76-79; 1984.
Chiolero, R.L. et al.; Assessment of changes in body water by bioimpedance in acutely ill surgical patients; Intensive Care Medicine; vol. 18, pp. 322-326; 1992.
Chumlea et al.; Bioelectrical Impedance and Body Composition: Present Status and Future Directions; Nutrition Reviews; vol. 52, No. 4, pp. 123-131; 1994.
Cornish, B.H. et al.; Quantification of Lymphoedema using Multi-frequency Bioimpedance; Applied Radiation and Isotopes; vol. 49, No. 5/6, pp. 651-652; 1998.
Cornish, B.H. et al.; Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes; Breast Cancer Research and Treatment; vol. 38, pp. 169-176; 1996.
Cornish, B.H. et al.; Data analysis in multiple-frequency bioelectrical impedance analysis; Physiological Measurement; vol. 19, No. 2, pp. 275-283; May 1, 1998.
Cornish, B.H. et al.; Alteration of the extracellular and total body water volumes measured by multiple frequency bioelectrical impedance analysis; Nutrition Research; vol. 14, No. 5, pp. 717-727; 1994.
Cornish, B.H. et al.; Early diagnosis of lymphedema using multiple frequency bioimpedance; Lymphology; vol. 34, pp. 2-11; Mar. 2001.
Cornish, B.H. et al.; Early diagnosis of lymphoedema in postsurgery breast cancer patients; Annals New York Academy of Sciences; pp. 571-575; May 2000.
Dines K.A. et al.; Analysis of electrical conductivity imaging; Geophysics; vol. 46, No. 7, pp. 1025-1036; Jul. 1981.
Ellis, K.J. et al; Human hydrometry: comparison of multifrequency bioelectrical impedance with 2H2O and bromine dilution; Journal of Applied Physiology; vol. 85, No. 3, pp. 1056-1062; 1998.
Forslund, A.H. et al.; Evaluation of modified multicompartment models to calculate body composition in healthy males; American Journal of Clinical Nutrition; vol. 63, pp. 856-862; 1996.
Gersing, E.; Impedance spectroscopy on living tissue for determination of the state of Organs; Bioelectrochemistry and Bioenergetics; vol. 45, pp. 145-149; 1998.
Gerth, W.A. et al.; A computer-based bioelectrical impedance spectroscopic system for noninvasive assessment of compartmental fluid redistribution; Third Annual IEEE Symposium on Computer Based Medical Systems, Jun. 3-6, 1990, University of NC. At Chapel Hill; pp. 446-453; Jun. 1990.
Gudivaka R. et al; Single- and multifrequency models for bioelectrical impedance analysis of body water compartments; Applied Physiology; vol. 87, Issue 3, pp. 1087-1096; 1999.
Jones, C.H. et al; Extracellular fluid volume determined by bioelectric impedance and serum albumin in CAPD patients; Nephrology Dialysis Transplantation; vol. 13, pp. 393-397; 1998.
Jossinet, J. et al.; A Study for Breast Imaging with a Circular Array of Impedance Electrodes; Proc. Vth Int. Conf. Bioelectrical Impedance, 1981, Tokyo, Japan; pp. 83-86; 1981.
Jossinet, J. et al.; Technical Implementation and Evaluation of a Bioelectrical Breast Scanner; Proc. 10.sup.th Int. Conf. IEEE Engng. Med. Biol., 1988, New Orleans, USA (Imped. Imaging II); vol. 1. p. 289; 1988.
Kanai, H. et al.; Electrcial Measurment of Fluid Distribution in Legs and Arms; Medical Progress through technology; pp. 159-170; 1987.
Kim, C.T. et al.; Bioelectrical impedance changes in regional extracellular fluid alterations; Electromyography and Clinical Neurophysiology; vol. 37, pp. 297-304; 1997.
Lozano, A. et al.; Two-frequency impedance plethysmograph: real and imaginary parts; Medical & Biological Engineering & Computing; vol. 28, No. 1, pp. 38-42; Jan. 1990.
Liu R. et al; Primary Multi-frequency Data Analyze in Electrical Impedance Scanning; Proceedings of the IEEE-EMBS 2005, 27th Annual International Conference of the Engineering in Medicine and Biology Society, Shanghai, China; pp. 1504-1507; , Sep. 1-4, 2005.
Lukaski, H.C. et al.; Estimation of Body Fluid Volumes Using Tetrapolar Bioelectrical Impedance Measurements; Aviation, Space, and Environmental Medicine; pp. 1163-1169; Dec. 1998.
Man, B. et al. Results of Preclinical Tests for Breast Cancer Detection by Dielectric Measurements; XII Int. Conf. Med. Biol. Engng. 1979, Jerusalem, Israel. Springer Int., Berlin; Section 30.4; 1980.
McDougal D., et al.; Body Composition Measurements From Whole Body Resistance and Reactance; Surgical Forum; vol. 36, pp. 43-44; 1986.
Osterman K.S. et al.; Multifrequency electrical impedance imaging: preliminary in vivo experience in breast; Physiological Measurement; vol. 21, No. 1, pp. 99-109; Feb. 2000.
Ott, M. et al.; Bioelectrical Impedance Analysis as a Predictor of Survival in Patients with Human Immunodeficiency Virus Infection; Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology; vol. 9, pp. 20-25; 1995.
Pethig, R. et al.; The Passive Electrical Properties of Biological Systems: Their Significance in Physiology, Biophysics and Biotechnology; Physics in Medicine and Biology; vol. 32, pp. 933-970; 1987.
Piperno, G. et al.; Breast Cancer Screening by Impedance Measurements; Frontiers of Medical & Biological Engineering; vol. 2, pp. 111-117; 1990.
Rigaud, B. et al.; Bioelectrical Impedance Techniques in Medicine; Critical Reviews in Biomedical Engineering; vol. 24 (4-6), pp. 257-351; 1996.
Schneider, I.; Broadband signals for electrical impedance measurements for long bone fractures; Engineering in Medicine and Biology Society, 1996. Bridging Disciplines for Biomedicine. Proceedings of the 18th Annual International Conference of the IEEE; vol. 5, pp. 1934-1935; Oct. 31, 1996.
Skidmore, R. et al.; A Data Collection System for Gathering Electrical Impedance Measurements from the Human Breast; Clinical Physics Physiological Measurement; vol. 8, pp. 99-102; 1987.
Sollish, B.D. et al.; Micropressor-assisted Screening Techniques; Israel Journal of Medical Sciences; vol. 17, pp. 859-864; 1981.
Steijaert, M. et al.; The use of multi-frequency impedance to determine total body water and extracellular water in obese and lean female individuals; International Journal of Obesity; vol. 21, pp. 930-934; 1997.
Surowiec, A.J. et al.; Dielectric Properties of Brest Carcinima and the Surrounding Tissues; IEEE Transactions on Biomedical Engineering; vol. 35, pp. 257-263; 1988.
Tedner, B.; Equipment Using Impedance Technique for Automatic Recording of Fluid-Volume Changes During Haemodialysis; Medical & Biological Engineering & Computing; pp. 285-290; 1983.
Thomas. B.J.; Future Technologies; Asia Pacific Journal Clinical Nutrition; vol. 4, pp. 157-159; 1995.
Thomas. B.J. et al.; Bioimpedance Spectrometry in Determination of Body Water Compartments: Accuracy and Clinical Significance; Applied Radiation and Isotopes; vol. 49, No. 5/6, pp. 447-455; 1998.
Thomas. B.J. et al.; Bioelectrical impedance analysis for measurement of body fluid volumes—A review; Journal of Clinical Engineering; vol. 17, No. 16, pp. 505-510; 1992.
Ulgen, Y. et al.; Electrical parameters of human blood; Engineering in Medicine and Biology Society, 1998. Proceedings of the 20th Annual International Conference of the IEEE; vol. 6, pp. 2983-2986; Nov. 1, 1998.
Ward, L.C. et al.; There is a better way to measure Lymphodema; National Lymphedema Network Newsletter; vol. 7, No. 4, pp. 89-92; Oct. 1995.
Woodrow, G. et al; Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis; Nephrology Dialysis Transplantation; vol. 15, pp. 862-866; 2000.
Bracco, D. et al., Bedside determination of fluid accumulation after cardiac surgery using segmental bioelectrical impedance, Critical Care Medicine, vol. 26, No. 6, pp. 1065-1070, 1998.
De Luca, F. et al., Use of low-frequency electrical impedance measurements to determine phospoholipid content in amniotic fluid; Physics in Medicine and Biology, vol. 41, pp. 1863-1869, 1996.
Deurenberg, P. et al., Multi-frequency bioelectrical impedance: a comparison between the Cole-Cole modelling and Hanai equations with the classicaly impedance index approach, Annals of Human Biology, vol. 23, No. 1, pp. 31-40, 1996.
Mattar, J.A., Application of Total Body Impedance to the Critically Ill Patient, New Horizons, vol. 4, No. 4, pp. 493-503, 1996.
Ward, L.C. et al., Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients, European Journal of Clinical Investigation, vol. 22, pp. 751-754, 1992.
Related Publications (1)
Number Date Country
20080319336 A1 Dec 2008 US